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Introduction: The growing prevalence of non-communicable diseases, combined with greater 
recognition of the effectiveness of lipid lowering agents (LLAs), has fueled their increasing use in 
recent years. Similarly, increasing recognition of mental health and, arguably, societal expectations 
and pressures has driven appreciable growth in antidepressant prescribing in recent years. 
Concurrent with this, growing resource pressures enhanced by the continual launch of new premium 
priced medicines necessitates reforms and initiatives within finite budgets. Scotland has introduced 
multiple measures in recent years to improve both the quality and efficiency of prescribing. There is a 
need to document these initiatives and outcomes to provide future direction. Method: Assessment of 
the utilization (items dispensed) and expenditure of key LLAs (mainly statins) and SSRIs between 
2001 and 2017 in Scotland alongside initiatives. Results: Multiple interventions have increased 
international non-proprietary name (INN) prescribing (99% for statins and up to 99.9% for SSRIs). 
They have also increased preferential prescribing of generic versus patented statins with low costs for 
generics, reduced inappropriate prescribing of ezetimibe due to effectiveness concerns, and 
increased the prescribing of higher dose statins (71% in 2015). These measures have resulted in a 
50% reduction in LLA expenditure between 2001 and 2015 despite a 412% increase in utilization. 
Initiatives to reduce the prescribing of escitalopram as lack of evidence demonstrating cost-benefits 
over generic citalopram, along with high INN prescribing, achieved a 73.7% reduction in SSRI 
expenditure between 2001 and 2017 despite a 2.34-fold increase in utilisation. Concerns with 
paroxetine, and more recently citalopram and escitalopram following safety warnings, resulted in a 
considerable reduction in their use alongside a significant increase in sertraline. Conclusion: Generic 
availability coupled with multiple measures has resulted in appreciable shifts in statin and SSRI 
prescribing behavior and reduced ezetimibe prescribing, resulting in improvements in both the quality 
and efficiency of prescribing to provide future direction. 
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